Pope Francis died on April 21, 2025, at age 88, weeks after being hospitalized for double pneumonia—a polymicrobial infection ...

Babies and children between the ages of three months and 11-years-old with pneumonia should be offered a three-day rather than five-day course of antibiotics, according to a new draft NICE guideline.

Clinical manifestations in HBoV-positive patients predominantly were fever and cough, with a clinical diagnosis of lower respiratory tract infection. Other viruses were also detected in 20% of ...

to extend the indication to include prevention of lower respiratory tract disease (LRTD) caused by RSV in individuals 18 through 59 years of age. This expands the previous authorization for ...

Reports say doctors have been recording cases of those affected under the classification “acute upper respiratory tract infection, unspecified." Emergency services are being advised in cases where ...

The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections ... A kidney infection can lead to fever, chills, lower back pain and vomiting.

Washington, United States—US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 million people around the world, mainly women, ...

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 million people around the world, mainly women, British pharmaceutical giant ...

Findings showed that IL-targeting biologics were associated with a 35% lower rate of serious infections (RR: 0.65, 95% CI: 0.48–0.88), while anti-TNF biologics showed no significant difference ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

Blujepa marks the first new oral antibiotic to gain FDA approval for uncomplicated urinary tract infections in nearly 30 years. The FDA has approved GSK’s Blujepa (gepotidacin), a first-in-class oral ...